Signal transduction by calcitonin Multiple ligands, receptors, and signaling pathways

Calcitonin (CT) is a peptide hormone that is secreted by the parafollicular cells of the thyroid in response to elevated serum calcium levels. It acts to reduce serum calcium by inhibiting bone resorption and promoting renal calcium excretion. In addition to this hypocalcemie effect, calcitonin modulates the renal transport of water and several ions other than calcium and acts on the central nervous system to induce analgesia, anorexia, and gastric secretion. The CT receptor, a member of a newly described family of serpentine G protein-coupled receptors, has recently been shown to couple to multiple trimeric G proteins, thereby activating several signaling proteins, including protein kinase C, cAMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase. In kidney proximal tubule cells (LLC-PK1), the CT-activated signaling mechanisms vary in a cell cycle-dependent manner, with the receptor coupling through a G(s) protein during G(2) phase and through a G(i) protein and possibly a G(q) protein during S phase. These signaling mechanisms differentially modulate the activities of Na(+)/K(+)-ATPase and the apical Na(+)/H(+) exchanger, effector molecules that play important roles in transepithelial Na(+) transport. Cloning of CT receptors has revealed the presence of alternatively spliced cassettes, resulting in the expression of different isoforms of the receptor. The availability of these recombinant CT receptors has allowed preliminary characterization of the effects of changes in the receptor's structure on its ligand binding and signal transduction properties. Thus, the cellular and molecular biology of CT is complex, with several structurally related peptide ligands and multiple isoforms of the CT receptor that can independently activate diverse signaling pathways. As the recent exciting results in this field are extended, we can expect rapid progress in understanding the molecular basis of the diverse effects of CT and, possibly, of the CT-related peptides CGRP and amylin.

[1]  H. Lodish,et al.  Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. , 1992, The Journal of clinical investigation.

[2]  K. Beaumont,et al.  Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin , 1993, FEBS letters.

[3]  M. Azria The Calcitonins: Physiology and Pharmacology , 1989 .

[4]  H. Datta,et al.  Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. , 1990, The Journal of endocrinology.

[5]  J. Meldolesi,et al.  Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. , 1989, The Journal of biological chemistry.

[6]  R. Baron,et al.  CELLULAR AND MOLECULAR BIOLOGY OF THE OSTEOCLAST , 1993 .

[7]  Aldons J. Lusis,et al.  Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.

[8]  R. Epand,et al.  Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. , 1990, Endocrinology.

[9]  H. Lodish,et al.  A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways. , 1992, Molecular endocrinology.

[10]  E. Murphy,et al.  Effects of calcitonin on cytosolic Ca in a suspension of rabbit medullary thick ascending limb tubules. , 1986, The American journal of physiology.

[11]  M. Zaidi,et al.  Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37). , 1991, Biochemical and biophysical research communications.

[12]  R. Ardaillou Kidney and calcitonin. , 1975, Nephron.

[13]  M. Zaidi,et al.  Further studies on the mode of action of calcitonin on isolated rat osteoclasts: pharmacological evidence for a second site mediating intracellular Ca2+ mobilization and cell retraction. , 1993, The Journal of endocrinology.

[14]  J. C. Clarke,et al.  Molecular cloning of the gene encoding the mouse parathyroid hormone/parathyroid hormone-related peptide receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Narumiya,et al.  Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity , 1993, Nature.

[16]  R. Baron,et al.  Cell cycle-dependent and kinase-specific regulation of the apical Na/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Sexton,et al.  Biologically active salmon calcitonin-like peptide is present in rat brain , 1992, Brain Research.

[18]  P. Bettica,et al.  Treatment with pertussis toxin does not prevent central effects of eel calcitonin , 1991, Peptides.

[19]  J. Vassalli,et al.  Calcitonin and calcitonin gene-related peptide interact with the same receptor in cultured LLC-PK1 kidney cells. , 1985, Biochemical and biophysical research communications.

[20]  W. Born,et al.  Calcitonin gene products: evolution, expression and biological targets. , 1987, Bone and mineral.

[21]  S. Goldring,et al.  Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family , 1993, Trends in Endocrinology & Metabolism.

[22]  L. Breimer,et al.  The calcitonin gene peptides: biology and clinical relevance. , 1990, Critical reviews in clinical laboratory sciences.

[23]  B. Hemmings,et al.  Isolation, characterization, and chromosomal localization of the porcine calcitonin receptor gene. Identification of two variants of the receptor generated by alternative splicing. , 1994, The Journal of biological chemistry.

[24]  R. Baron,et al.  Selective internalization of the apical plasma membrane and rapid redistribution of lysosomal enzymes and mannose 6-phosphate receptors during osteoclast inactivation by calcitonin. , 1990, Journal of cell science.

[25]  G. Giebisch,et al.  The Proximal Nephron , 1978 .

[26]  R. L. Moss,et al.  Neuronal membrane sensitivity to a salmon calcitonin analogue with negligible ability to lower serum calcium , 1988, Neuroscience Letters.

[27]  D Chatterjee,et al.  Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. , 1991, Science.

[28]  P. Sexton,et al.  Identification of brain isoforms of the rat calcitonin receptor. , 1993, Molecular endocrinology.

[29]  R. Baron,et al.  Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. , 1992, Endocrinology.

[30]  F. Morel,et al.  Adenylate cyclase responsiveness to hormones in various portions of the human nephron. , 1980, The Journal of clinical investigation.

[31]  D. Goltzman,et al.  Calcitonin receptors in the central nervous system of the rat. , 1981, Endocrinology.

[32]  D. Copp,et al.  Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium. , 1962, Endocrinology.

[33]  Y. Kawaguchi,et al.  Heterogeneous response of cytoplasmic free Ca2+ in proximal convoluted and straight tubule cells in primary culture. , 1989, American Journal of Physiology.

[34]  A. Vignery,et al.  Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. , 1992, The Journal of biological chemistry.

[35]  D. Hr,et al.  Natriuretic effect of calcitonin in man. , 1971 .

[36]  M. Zaidi,et al.  Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin. , 1992, The Journal of endocrinology.

[37]  J. Gallagher,et al.  Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes. , 1988, European journal of pharmacology.

[38]  S. Nicosia,et al.  Inhibitory effects of calcitonin on adenylate cyclase activity in different rat brain areas. , 1986, Life sciences.

[39]  H. Kawashima,et al.  Calcitonin selectively stimulates 25-hydroxyvitamin D3-1α-hydroxylase in proximal straight tubule of rat kidney , 1981, Nature.

[40]  T. Berndt,et al.  Proximal tubule site of inhibition of phosphate reabsorption by calcitonin. , 1984, American Journal of Physiology.

[41]  Laurent Journot,et al.  Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.

[42]  David E. Clapham,et al.  New roles for G-protein (βγ-dimers in transmembrane signalling , 1993, Nature.

[43]  H. Lodish,et al.  Expression cloning of an adenylate cyclase-coupled calcitonin receptor. , 1991, Science.